Medications
Browse Related Strategy Recommendations
Improve adolescents’ access to MH/SUD medications
The U.S. Food and Drug Administration (FDA) should work to improve adolescents’ access to the best mental health and substance use disorder (MH/SUD) medications by bridging available adult data with bioequivalence studies and an open-label safety study.